BriaCell Therapeutics Corp. (BCTX) vs Nephros, Inc. (NEPH)

A side-by-side comparison of BriaCell Therapeutics Corp. and Nephros, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
BriaCell Therapeutics Corp. logo
BCTX
BriaCell Therapeutics Corp.
$35M
$4.02HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Nephros, Inc. logo
NEPH
Nephros, Inc.
$33M
$3.02HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — BCTX vs NEPH

growth of $100 · dividends reinvested · last 10y
BCTX -99.9% (-52.2%/yr)NEPH +6.6% (+0.6%/yr)NEPH compounded faster over this window
Log scale — wide-divergence pair
001101001kStart $10020182020202220242026$0$107
BCTX NEPH

BCTX vs NEPH: by the numbers

  • •BCTX is the larger company ($35M vs $33M market cap).
  • •NEPH is profitable (8.38% net margin) while BCTX runs a net loss (0.00%).

Metrics side by side

Valuation

MetricBCTXNEPH
P/E ratioN/A19.03
Forward P/EN/A19.28
P/S ratioN/A1.58
P/B ratio1.452.74
EV / EBITDAN/A16.41

Profitability

MetricBCTXNEPH
Gross margin0.00%60.31%
Operating margin0.00%7.92%
Net margin0.00%8.38%
ROE-154.06%14.51%
ROIC-164.58%12.67%

Growth (annualized)

MetricBCTXNEPH
Revenue CAGR (5Y)N/A16.99%
Total return CAGR (5Y)-67.32%-15.93%

Frequently asked

Is BCTX or NEPH more profitable?
NEPH runs the higher net margin — BCTX at 0.00% versus NEPH at 8.38%.
How have BCTX and NEPH total returns compared?
Over the past 10 years, BCTX delivered -52.81% and NEPH delivered 1.80% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BCTX analysisFull NEPH analysisInteractive comparison tool

Dig into the metrics

Nephros P/E ratioBriaCell Therapeutics ROENephros ROEBriaCell Therapeutics operating marginNephros operating marginBriaCell Therapeutics revenue growthNephros revenue growthBriaCell Therapeutics free cash flowNephros free cash flow

BriaCell Therapeutics & Nephros appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.